glp 1 hfpef In patients with cardiometabolic #HFpEF, #semaglutide and #tirzepatide reduced the risk of hospitalization for heart failure or all-cause mortality vs sitagliptin, but tirzepatide offered no additional benefit over semaglutide. https://ja.ma/3JO2SQc Select A Pharmacy:Foxrock GLP-1 receptor agonists are Form_Capsule

glp 1 hfpef In patients with cardiometabolic #HFpEF, #semaglutide and #tirzepatide reduced the risk of hospitalization for heart failure or all-cause mortality vs sitagliptin, but tirzepatide offered no additional benefit over semaglutide. https://ja.ma/3JO2SQc Select A Pharmacy:Foxrock GLP-1 receptor agonists are Form_Capsule

GLP-1 receptor agonists are increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal.

doi: 10.1111/obr.12143, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar] 40.Garrow JS, Summerbell CD

Form_Capsule

Select A Pharmacy:Foxrock

Recent study has shown that Exenatide and Liraglutide improve insulin sensitivity and lower fasting and postprandial blood glucose in T1D patients who do not make their own insulin